Gestational trophoblastic neoplasia epidemiology and demographics

Gestational trophoblastic neoplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gestational trophoblastic neoplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gestational trophoblastic neoplasia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gestational trophoblastic neoplasia epidemiology and demographics
CDC on Gestational trophoblastic neoplasia epidemiology and demographics
Gestational trophoblastic neoplasia epidemiology and demographics in the news
Blogs on Gestational trophoblastic neoplasia epidemiology and demographics
Directions to Hospitals Treating Gestational trophoblastic neoplasia
Risk calculators and risk factors for Gestational trophoblastic neoplasia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overveiw

The incidence of choriocarcinoma is approximately 110-120 per 100,000 pregnancies.

Epidemiology and Demographics

Incidence

• The reported incidence of choriocarcinoma in the United States is about 110 to 120 per 100,000 pregnancies
• The reported incidence of choriocarcinoma, the most aggressive form of GTD, in the United States is about 2 to 7 per 100,000 pregnancies
• The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is about 0.18 per 100,000 women between the ages of 15 years and 49 years